comprised of just the BRCT I domain and the linker ysis of native XRCC1 from HeLa cells confirmed that this region is phosphorylated in vivo, identifying a phosregion containing the CK2 sites, was similarly phosphorylated. In contrast, the NTD of human XRCC1 was not phopeptide spanning amino acids 503-546 that was a mixture of tri-and tetraphosphorylated species (Figures phosphorylated by CK2, and the C-terminal BRCT domain was dispensable for phosphorylation. These data 1D and 1G). This suggests that, in addition to the primary CK2 sites S518 and T523, the "atypical" CK2 sites T519 suggest that XRCC1 is a phosphoprotein in eukaryotic cells and that the linker between the two BRCT domains and S525 within this region are also phosphorylated. A synthetic peptide spanning residues 482-494 that is phosphorylated by CK2 in vitro.
To examine which of the primary CK2 sites within the included the primary CK2 site T488 was also phosphorylated in vitro, and this region was similarly phosphorylinker domain might be phosphorylated, we compared the phosphorylation of four synthetic peptides spanning lated in cells. Surprisingly, the tryptic peptide that encompassed this region, spanning residues 459-494, was these sites ( Figure 1D ). In addition, XRCC1 was immunoprecipitated from HeLa cell extracts and tryptic fragcomprised of uni-, bi-, tri-, and tetraphosphorylated species. In addition to T488, this peptide contains an "atypiments were analyzed by mass spectroscopy. A synthetic peptide spanning residues 514-530 and including cal" CK2 site at S475 and a hierarchical CK2 site at S485, which becomes a classical CK2 site following the CK2 sites S518 and T523 exhibited the highest affinity and phosphorylation rate of those tested, with the phosphorylation at T488. A synthetic peptide spanning residues 401-427 and including the primary CK2 sites latter parameter as rapid as an optimal CK2 peptide substrate ( Figures 1D and 1F) . Mass spectroscopic anal-S408, S409, S410, and S421 was also phosphorylated S-XRCC1, irrespective of whether or not this probe was phosphorylated. also phosphorylated in vivo. Finally, a synthetic peptide spanning the primary CK2 site T453 was not phosphoryWe have previously shown that XRCC1 purified from E. coli stimulates PNK activity and SSBR reactions in lated in vitro, and this residue was similarly not phosphorylated in vivo (J.Q., unpublished data). In summary, which PNK is limiting (Whitehouse et al., 2001). We therefore examined whether PNK activity was higher in the the C-terminal linker region in XRCC1 is phosphorylated in vitro and in vivo at a minimum of eight sites, including presence of phosphorylated XRCC1 than mock-phosphorylated XRCC1. Indeed, the 5Ј-DNA kinase activity at least three primary CK2 consensus sites and four atypical or hierarchical CK2 sites.
of PNK was greater if XRCC1 was phosphorylated than if it was not, in reactions in which the DNA kinase activity was rate limiting ( Figure 2C ). In addition, the efficiency XRCC1 Phosphorylation by CK2 Stimulates of SSBR reactions reconstituted with purified proteins PNK Binding In Vitro was greater in the presence of Sf XRCC1 (or Ec XRCC1 We have reported previously that XRCC1 interacts with preincubated with CK2) than with nonphosphorylated and stimulates human polynucleotide kinase (WhiteEc XRCC1 ( Figure 2D ). Together, these data suggest house et al., 2001 ). To examine whether XRCC1 phosthat phosphorylation of XRCC1 by CK2 stimulates PNK phorylation by CK2 influences PNK interaction, recombibinding, activity, and also SSBR reactions in vitro. nant human XRCC1 purified from E. coli or insect cells was dot blotted onto nitrocellulose with or without prior phosphorylation by recombinant CK2 and compared for XRCC1 Phosphorylated by CK2 Interacts with the FHA Domain of PNK its ability to bind human Figures 1E and 3C) . Similar results were observed when these XRCC1 fragments were exis located near these sites. In undamaged EM9-XH cells, XRCC1 was detected as a diffuse nuclear stain (Figure amined for PNK interaction using yeast two-hybrid analysis (data not shown). Importantly, pretreatment with 4A, top panels). However, after exposure to H 2 0 2 followed by a 10 min incubation in drug-free media to CK2 was not necessary for interaction of breakage. This is consistent with a requirement for additional phosphorylation of XRCC1 by CK2 during SSBR.
Proteins, Cell Lines, and Expression Constructs
In this regard, the observation from mass spectroscopic (1.5 mg/ml). In the case of EM9-PNK/XH, EM9-PNK/XH CKM , EM9-XH/CK2␣, and EM9-XH/CK2␣ V66A cells, EM9 cells were transfected
